SEL

Selank

Cognitive Immune Approved outside US

Synthetic analog of the immunomodulatory peptide tuftsin, with anxiolytic-like effects reported in rodent models and limited human data. Developed alongside Semax in Russia.

Regulatory status (as of Sept 2026)

Not FDA-approved; not among the six peptides PCAC recommended for the 503A Bulks List in July 2026.

See the FDA peptide regulatory tracker · Read our July 27, 2026 dispatch on the FDA PCAC peptide vote
Educational summary. Every effect described below is drawn from the cited published research and describes what was observed in research subjects — not a promise of results, a dose recommendation, or an endorsement for human use. Many peptides are not FDA-approved. Consult a licensed healthcare provider before making any health decision. Full disclaimer.

4 studies referenced · Last reviewed Oct 1, 2026 · Reviewed by The Peptide Dispatch Editorial Team · How we research & label content

TL;DR — Selank at a Glance

Selank is approved as a medicine in some countries outside the US, but not by the FDA. Synthetic analog of the immunomodulatory peptide tuftsin, with anxiolytic-like effects reported in rodent models and limited human data.

Half-lifeNot established in published research
How it's given in studiesIntranasal
Research stageApproved outside US
Dosing
Published research: 0.3 mg/kg intraperitoneal (anxiolytic dose) in rats and mice
details0.3 mg/kg i.p. (anxiolytic dose) in rats and mice; single injection in healthy human volunteers in an fMRI study (n=52, dose not in abstract)
Community-reportedCommunity-reported: 250–500 mcg, intranasal

Published-research dosing is what was given in the cited studies (species and units as reported). Community-reported dosing is what users describe, not from clinical studies. Neither is a recommendation. Not medical advice.

Where each point comes from: Clinicalhuman trials and FDA labels   Lab / animalrodent, cell and ex vivo studies   Community-reporteduser experience and commonly used protocols, not from clinical studies

How It Works

In plain terms: It is a lab-made peptide thought to act on the brain's calming (GABA) system, based mostly on animal studies. Proposed mechanism, from animal studies and a review: a synthetic tuftsin analogue proposed to act on GABA-related systems (review, Doyno 2021). Anxiolytic-like effects were reported in rats (Kasian 2017); a human fMRI study (n=52 healthy volunteers) examined its effects on resting-state brain connectivity (Panikratova 2020).

Effects Reported in Research

How to read this: Each item below is an effect observed in research subjects in the cited studies — think of Dexter, our stand-in research subject. These are findings from the literature, not results you should expect, and not medical advice.

  • Lab / animalIn rats under chronic mild stress: enhanced the anxiety-reducing effect of diazepam (Kasian 2017)
  • Lab / animalAnxiolytic-like effects in rodent models; limited human data

What Users Report (Community, Not Clinical)

Commonly reported protocol

Community-reportedCommonly reported doses range from 250 to 500 mcg (intranasal). This is not a recommendation.

What users report

  • Community-reportedCognitive enhancement
  • Community-reportedImmune modulation
  • Community-reportedMood stabilization

Side effects users report

  • Community-reportedFatigue
  • Community-reportedMild headache

Side effects reported in studies are listed separately below.

Community reports are anecdotal, vary widely in product quality and purity, and are not medical advice. Talk to a licensed provider.

Side Effects and Safety Notes

  • Human safety data outside Russia are limited

N-acetyl Selank

N-acetyl Selank is an acetylated form of Selank. No published studies of this modified form were found, and there is no evidence that it shares Selank’s pharmacology. Findings on this page are for Selank.

References

  1. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
    Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P et al. Behavioural neurology. 2017. PMID: 28280289.
    Study type: Rat chronic stress model.
    DOI: 10.1155/2017/5091027 · PubMed
  2. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
    Konstantinopolsky MA, Chernyakova IV, Kolik LG. Bulletin of experimental biology and medicine. 2022. PMID: 36322304.
    Study type: Rat, 0.3 mg/kg i.p..
    DOI: 10.1007/s10517-022-05624-x · PubMed
  3. Functional Connectomic Approach to Studying Selank and Semax Effects
    Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV et al. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. 2020. PMID: 32342318.
    Study type: Human fMRI, n=52 healthy volunteers.
    DOI: 10.1134/S001249662001007X · PubMed
  4. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank
    Doyno CR, White CM. Journal of clinical pharmacology. 2021. PMID: 34396551.
    Study type: Review.
    DOI: 10.1002/jcph.1922 · PubMed

Get the weekly Dispatch

New research, FDA peptide updates, and what users are reporting. One email a week. Unsubscribe anytime.

How Selank Compares

PeptideHalf-LifeRouteResearch Status
SelankNo published PK data foundIntranasalApproved outside US
DihexaUnknownOral or intraperitoneal (rodent studies only); no human administration publishedPreclinical (animal)
FGL (L)UnknownSubcutaneous injectionPreclinical (animal)
P21UnknownOral (mice)Preclinical (animal)
PE-22-28No published PK data foundSubcutaneous injection, IntranasalPreclinical (animal)

Values reflect figures reported in published research. Compare any peptides side-by-side →

Compare Selank with…

Frequently Asked Questions

What is Selank?
Synthetic analog of the immunomodulatory peptide tuftsin, with anxiolytic-like effects reported in rodent models and limited human data. Developed alongside Semax in Russia.
How does Selank work?
In plain terms: It is a lab-made peptide thought to act on the brain's calming (GABA) system, based mostly on animal studies. Proposed mechanism, from animal studies and a review: a synthetic tuftsin analogue proposed to act on GABA-related systems (review, Doyno 2021). Anxiolytic-like effects were reported in rats (Kasian 2017); a human fMRI study (n=52 healthy volunteers) examined its effects on resting-state brain connectivity (Panikratova 2020).
What is the research status of Selank?
Selank is at the following stage in the published literature: Approved outside US. All information is for research and educational purposes only.
What is the half-life of Selank?
Reported half-life: No published PK data found.
How is Selank administered in research?
Reported administration route in the literature: Intranasal. This is not a recommendation for human use.

Quick Actions

Category

This peptide belongs to the Cognitive category. View All Cognitive Peptides

Related Categories

Immune

Related Peptides

From Our Affiliated Clinic

Prefer physician oversight? See how 1836 Wellness works.

1836 Wellness is a physician-supervised clinic in Houston, TX. Discussing a compound on this page is not an offer to prescribe or supply it.

See how it works →

Disclosure: The Peptide Dispatch and 1836 Wellness are commonly owned by 1836 Wellness LLC. We may benefit financially if you become a client of 1836 Wellness. Learn more.

Sources & Methodology

Dosing, half-life figures, and mechanism descriptions on this page are compiled from peer-reviewed published research, with the species and study type stated where reported. Figures labeled “Dosing used in published research” describe what was given in those studies and do not constitute dosing recommendations for any human use. Each cited paper is listed with DOI and PubMed links in the References section above. Found an error? Contact us.

← Back to Peptide Library Dosing Calculator The Dispatch Home